PRME
PRME
US74168J1016
Prime Medicine, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
723.69M EUR
666.92M EUR
628.54M EUR
626.38M EUR
Enterprise Value
654.3M EUR
731.95M EUR
678.95M EUR
679.78M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-4.49x
--
--
--
Price to Sales
177.68x
163.74x
155.81x
197.1x
Price to Book
17.73x
0.33x
8.19x
5.18x
EV/Revenue
160.64x
179.71x
168.31x
213.9x
EV/EBITDA
-3.46x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-10.47%
-23.52%
-25.26%
-18.49%
ende